✓ Early-stage friendly

Towards a European production of stable isotopes for novel nuclear medicine therapies 2026 Grant

••••• organisation

An organisation

Summary

This grant funds research and innovation towards establishing European production capacity for stable isotopes used in advanced nuclear medicine therapies. It targets research institutions and consortia developing novel isotope production methods and supply chains for medical applications.

Summary by Raise Lens from the official notice · 10 Jun 2026Accurate?

About this grant

Towards a European production of stable isotopes for novel nuclear medicine therapies (SAMIRA/ERVI)

Unlock the funder, link and full detail

Create a free account to unlock 3 full listings a month, including the funder name, the application link and the complete programme detail.

Create free account →See Pro

Frequently asked questions

How much funding does this grant offer?: Towards a European production of stable isotopes for novel nuclear medicine therapies offers Up to €2M.
When is the Towards a European production of stable isotopes for novel nuclear medicine therapies deadline?: Applications close 15 Sep 2026 (13 days left).
Who can apply for Towards a European production of stable isotopes for novel nuclear medicine therapies?: Eligibility covers organisations in EU; research-institution, university, consortium, large-company. The full eligibility conditions are part of the Pro detail.